CRDL
Cardiol Therapeutics Inc.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 9/23/2026 | View on SEC |
| 6-K | 9/23/2026 | View on SEC |
| SUPPL | 9/16/2026 | View on SEC |
| F-10/A | 9/16/2026 | View on SEC |
| 6-K | 9/16/2026 | View on SEC |
| 6-K | 9/15/2026 | View on SEC |
| 6-K | 9/11/2026 | View on SEC |
| 6-K | 9/10/2026 | View on SEC |
| F-X | 9/10/2026 | View on SEC |
| F-10 | 9/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CRDL |
| Company Name | Cardiol Therapeutics Inc. |
| CIK | 1702123 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | A6 |
| Phone | 289-910-0850 |